StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a one year low of $0.01 and a one year high of $1.99. The firm has a market cap of $833,000.00, a price-to-earnings ratio of 0.00 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- How to invest in marijuana stocks in 7 steps
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- How to Calculate Stock Profit
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
